Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The IKK/NF-κB signaling pathway requires Morgana to drive breast cancer metastasis
Federica Fusella, Laura Seclì, Elena Busso, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
Milica Nedeljković, Ana Damjanović
Cells (2019) Vol. 8, Iss. 9, pp. 957-957
Open Access | Times Cited: 658
Evidence for the Involvement of the Master Transcription Factor NF-κB in Cancer Initiation and Progression
Yu Puar, Muthu K. Shanmugam, Lu Fan, et al.
Biomedicines (2018) Vol. 6, Iss. 3, pp. 82-82
Open Access | Times Cited: 172
Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components
Guangzhao Guan, Richard D. Cannon, Dawn Coates, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 272-272
Open Access | Times Cited: 40
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer
Linjiang Song, Xian Chen, Ling Mi, et al.
Cancer Science (2020) Vol. 111, Iss. 11, pp. 4242-4256
Open Access | Times Cited: 133
Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer
Billy Samuel Hill, Annachiara Sarnella, Giuliana D’Avino, et al.
Seminars in Cancer Biology (2019) Vol. 60, pp. 202-213
Open Access | Times Cited: 114
The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese, Samson Mathews Samuel, Mariam Abotaleb, et al.
Cancers (2018) Vol. 10, Iss. 10, pp. 346-346
Open Access | Times Cited: 94
An Insight Into the Cancer Stem Cell Survival Pathways Involved in Chemoresistance in Triple-Negative Breast Cancer
Hina Qayoom, Nissar Ahmad Wani, Bader Alshehri, et al.
Future Oncology (2021) Vol. 17, Iss. 31, pp. 4185-4206
Closed Access | Times Cited: 79
Phytoconstituents as modulators of NF-κB signalling: Investigating therapeutic potential for diabetic wound healing
Jagat Pal Yadav, Amita Verma, Prateek Pathak, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117058-117058
Open Access | Times Cited: 11
Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight
Rutuja Damare, Kritika Engle, Gautam Kumar
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2406-2447
Closed Access | Times Cited: 10
Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways
Lokman Varışlı, Osman Çen, Spiros Vlahopoulos
Immunology (2019) Vol. 159, Iss. 3, pp. 257-278
Open Access | Times Cited: 68
Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
Li Chen, Xiangyi Kong, Zhongzhao Wang, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 5, pp. 2993-3021
Open Access | Times Cited: 63
P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa
Giovanna Carrà, Marcello Francesco Lingua, Beatrice Maffeo, et al.
Cellular and Molecular Life Sciences (2020) Vol. 77, Iss. 22, pp. 4449-4458
Open Access | Times Cited: 62
Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer
Zhen Zhao, Yuanke Li, Hao Liu, et al.
Science Advances (2020) Vol. 6, Iss. 29
Open Access | Times Cited: 61
Characterization of a small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal cancer growth
Zhenlong Yu, Jian Gao, Xiaolei Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
ROS mediated Cu[Fe(CN)5NO] nanoparticles for triple negative breast cancer: A detailed study in preclinical mouse model
Sanchita Tripathy, Shagufta Haque, Swapnali Londhe, et al.
Biomaterials Advances (2024) Vol. 160, pp. 213832-213832
Closed Access | Times Cited: 6
An Immune‐Regulating Polysaccharide Hybrid Hydrogel with Mild Photothermal Effect and Anti‐Inflammatory for Accelerating Infected Wound Healing
ShengZhe Zhou, Xueliang Zhang, Wei Ni, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 5
IL-17 induces the proliferation and migration of glioma cells through the activation of PI3K/Akt1/NF-κB-p65
Bin Wang, Chenhui Zhao, Guan Sun, et al.
Cancer Letters (2019) Vol. 447, pp. 93-104
Closed Access | Times Cited: 51
<p>Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator</p>
Li Chen, Xiangyi Kong, Zhongzhao Wang, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 1543-1567
Open Access | Times Cited: 48
A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment
Wei Zhang, Yimin Shen, Huanhuan Huang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 40
Inhibition of NF-κB-Mediated Proinflammatory Transcription by Ru(II) Complexes of Anti-Angiogenic Ligands in Triple-Negative Breast Cancer
Ayan Chakraborty, Shilpendu Ghosh, Manas Pratim Chakraborty, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5902-5923
Closed Access | Times Cited: 4
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter
Roberto Ruiu, Valeria Rolih, Elisabetta Bolli, et al.
Cancer Immunology Immunotherapy (2018) Vol. 68, Iss. 1, pp. 131-141
Open Access | Times Cited: 45
Selection of Metastatic Breast Cancer Cell-Specific Aptamers for the Capture of CTCs with a Metastatic Phenotype by Cell-SELEX
Wanming Li, Linlin Zhou, Min Zheng, et al.
Molecular Therapy — Nucleic Acids (2018) Vol. 12, pp. 707-717
Open Access | Times Cited: 41
MicroRNA-708 activation by glucocorticoid receptor agonists regulate breast cancer tumorigenesis and metastasis via downregulation of NF-κB signaling
K. J. Senthil Kumar, M. Gokila Vani, Hen-Wen Hsieh, et al.
Carcinogenesis (2019) Vol. 40, Iss. 2, pp. 335-348
Closed Access | Times Cited: 37
A comprehensive review of anticancer mechanisms of action of Alantolactone
Ghader Babaei, Shiva Gholizadeh‐Ghaleh Aziz, Masoumeh Rajabi Bazl, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111231-111231
Open Access | Times Cited: 31
Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
Yuan Cai, Kewa Gao, Bi Peng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top